--- title: "Integrated BioPharma (INBP) news: convertible notes" url: "https://aibio.space/companies/integrated-biopharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "INBP convertible notes news: Integrated BioPharma extends PNC revolving credit line to April 14, 2027. Integrated BioPharma, Inc. (OTC: INBP), United States." --- INBP Integrated BioPharma, Inc. OTC · United States # Integrated BioPharma (INBP) news INBP convertible notes news Distress · 2026-07-02 ## [Integrated BioPharma extends PNC revolving credit line to April 14, 2027](https://aibio.space/news/integrated-biopharma-extends-pnc-revolving-credit-line-april-14-2027/) The $4,000,000.00 PNC line now runs to April 14, 2027, and a new Convertible ELOC of up to $250,000.00 replaces a matured $500,000.00 equipment note. ## Latest Integrated BioPharma news We have not published a story on Integrated BioPharma yet. When there is news, it will appear here. ## Integrated BioPharma at a glance - **Ticker**: INBP - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $4.5 million ### Related companies - [Aytu BioPharma](https://aibio.space/companies/aytu-biopharma/) NASDAQ: AYTU - [Skinvisible](https://aibio.space/companies/skinvisible/) OTC: SKVI - [Damora Therapeutics](https://aibio.space/companies/damora-therapeutics/) NASDAQ: DMRA - [Accustem Sciences](https://aibio.space/companies/accustem-sciences/) OTC: ACUT - [Mirum Pharmaceuticals](https://aibio.space/companies/mirum-pharmaceuticals/) NASDAQ: MIRM - [Turn Therapeutics](https://aibio.space/companies/turn-therapeutics/) NASDAQ: TTRX - [NOVACCESS GLOBAL INC.](https://aibio.space/companies/novaccess-global/) OTC: XSNX - [AEON Biopharma](https://aibio.space/companies/aeon-biopharma/) AMEX: AEON ### Also on OTC - [Carisma Therapeutics](https://aibio.space/companies/carisma-therapeutics/) CARM - [ENvue Medical](https://aibio.space/companies/envue-medical/) FEED - [Altamira Therapeutics](https://aibio.space/companies/altamira-therapeutics/) CYTOF - [MabCure](https://aibio.space/companies/mabcure/) MBCI - [Plandai Biotechnology](https://aibio.space/companies/plandai-biotechnology/) PLPL - [Harbor Diversified](https://aibio.space/companies/harbor-diversified/) HRBR ## Integrated BioPharma annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Net income (loss) | [-$2.8 million](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | [$808,000](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | | Cash from operations | [$1.2 million](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | [$2.1 million](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | | Cash and equivalents | [$4.5 million](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | [$3.6 million](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/) | Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $4.5 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Integrated BioPharma Has Integrated BioPharma sold convertible notes? Our latest story on this, dated Jul 2, 2026: "Integrated BioPharma extends PNC revolving credit line to April 14, 2027". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/integrated-biopharma-extends-pnc-revolving-credit-line-april-14-2027/). What is the ticker symbol of Integrated BioPharma? Integrated BioPharma, Inc. trades under the ticker INBP on OTC. Where is Integrated BioPharma listed? Integrated BioPharma, Inc. is listed on OTC. What is the SEC CIK of Integrated BioPharma? The SEC Central Index Key (CIK) for Integrated BioPharma, Inc. is 1016504. Its filings are on SEC EDGAR. How many shares does Integrated BioPharma have outstanding? 31,059,610 shares as of 2026-09-23, per the cover page of its 10-K filed 2026-09-25. Which country or territory is Integrated BioPharma listed under? Our directory records Integrated BioPharma, Inc. under United States. What does Integrated BioPharma do? Our directory classifies Integrated BioPharma, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Integrated BioPharma? The ISIN recorded for Integrated BioPharma, Inc. is US45811V1052. Does aibio.space cover Integrated BioPharma? aibio.space lists Integrated BioPharma, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Integrated BioPharma incorporated? SEC records list its state or country of incorporation as DE. Is Integrated BioPharma profitable? Integrated BioPharma, Inc. reported a net loss of $2.8 million for the fiscal year ended Jun 30, 2026, and generated $1.2 million of cash from operations, per its annual report to the SEC. How much cash does Integrated BioPharma have? $4.5 million in cash at Jun 30, 2026, per its 10-K. What is the latest Integrated BioPharma (INBP) stock news? Our latest story on Integrated BioPharma, dated Jul 2, 2026: "Integrated BioPharma extends PNC revolving credit line to April 14, 2027". The $4,000,000.00 PNC line now runs to April 14, 2027, and a new Convertible ELOC of up to $250,000.00 replaces a matured $500,000.00 equipment note. [Source](https://aibio.space/news/integrated-biopharma-extends-pnc-revolving-credit-line-april-14-2027/). Is Integrated BioPharma in financial distress? Our latest distress story, dated Jul 2, 2026: "Integrated BioPharma extends PNC revolving credit line to April 14, 2027". The $4,000,000.00 PNC line now runs to April 14, 2027, and a new Convertible ELOC of up to $250,000.00 replaces a matured $500,000.00 equipment note. [Source](https://aibio.space/news/integrated-biopharma-extends-pnc-revolving-credit-line-april-14-2027/). What is Integrated BioPharma's market cap? We do not publish live share prices. In its annual report, Integrated BioPharma, Inc. put the market value of shares held by non-affiliates (public float) at $3.4 million as of Dec 31, 2025. ## Investor discussion: Integrated BioPharma Members talk about Integrated BioPharma (INBP). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Integrated BioPharma, newest first. Each line links the filing it comes from. 1. 2026-07-02 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.01,1.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1016504/000143774926022415/inbp20260630_8k.htm) 2. 2025-04-24 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1016504/000143774925012917/inbp20250422_8k.htm) 3. 2025-04-21 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.01,1.02,2.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1016504/000143774925012475/inbp20250417c_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:INBP on TradingView](https://www.tradingview.com/symbols/OTC-INBP/). ## SEC filings and registration - **SEC name**: Integrated Biopharma Inc - **CIK**: 1016504 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: INBP (OTC) - **State or country of incorporation**: DE - **Fiscal year ends**: June 30 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 225 LONG AVENUE, HILLSIDE, NJ, 07205 - **Phone**: 9739260816 - **Shares outstanding**: 31,059,610 as of 2026-09-23 (10-K filed 2026-09-25) - **Former names**: INTEGRATED HEALTH TECHNOLOGIES INC; CHEM INTERNATIONAL INC ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031247/inbp20260925_8k.htm) filed 2026-09-25 - [10-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926031241/inbp20260630_10k.htm) filed 2026-09-25 - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926028628/inbp20260820_8k.htm) filed 2026-08-20 - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926022415/inbp20260630_8k.htm) filed 2026-07-02 - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926015928/inbp20260507_8k.htm) filed 2026-05-08 - [10-Q](https://www.sec.gov/Archives/edgar/data/1016504/000143774926015899/inbp20260331_10q.htm) filed 2026-05-08 - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/inbp20260415_8k.htm) filed 2026-04-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1016504/000143774926004553/inbp20260217_8k.htm) filed 2026-02-18 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001016504), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Integrated BioPharma, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker INBP, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Integrated BioPharma, Inc. - **Ticker**: INBP - **Listing**: OTC - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US45811V1052 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-INBP/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/integrated-biopharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Integrated BioPharma (INBP) news: convertible notes", 2026-10-31, https://aibio.space/companies/integrated-biopharma/